Estrogen inhibits endothelin-1 production and c-fos gene expression in rat aorta

Atherosclerosis

Volumn 125, Issue 1, 1996, Pages 27-38

  Akishita, Masahiro ^a   Ouchi, Yasuyoshi ^a   Miyoshi, Hideyuki ^a   Orimo, Akira ^a   Kozaki, Koichi ^a   Eto, Masato ^a   Ishikawa, Michiro ^a   Kim, Seungbum ^a   Toba, Kenji ^a   Orimo, Hajime ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Atherosclerosis; c fos; Endothelin; Estrogen; Smooth muscle cell

Indexed keywords

ENDOTHELIN 1; ESTRADIOL; MESSENGER RNA;

ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; DNA SYNTHESIS; DOWN REGULATION; ESTROGEN ACTIVITY; FEMALE; FEMORAL ARTERY; GENE EXPRESSION REGULATION; HORMONAL REGULATION; LIPID METABOLISM; NONHUMAN; ONCOGENE C FOS; OVARIECTOMY; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0030598979     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(96)05836-4     Document Type: Article

References (51)

1. [1] Kannel WB, Hjortland MC. McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: The Framingham Study. Ann Intern Med 1976;85:447-452.
2. [2] Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987;316:1105-1110.
3. [3] Bush TL, Barrett-Conner E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, Tyroler HA, Rifkind BM. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 1987;75:1102-1109.
4. [4] Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses' Health Study. N Engl J Med 1991;325:756-762.
5. [5] Kushwaha RS, Hazzard WR. Exogenous estrogens attenuate dietary hypercholesterolemia and atherosclerosis in the rabbit. Metabolism 1981;30:359-366.
6. [6] Adams MR, Clarkson TB, Kaplan JR, Koritnik DR. Experimental evidence in monkeys for beneficial effects of estrogen on coronary artery atherosclerosis. Transplant Proc 1989;21:3662-3664.
7. [7] Cheng LP, Kuwahara M, Jacobsson J, Foegh ML. Inhibition of myointimal hyperplasia and macrophage infiltration by estradiol in aorta allografts. Transplantation 1991;52:967-972.
8. [8] Lobo RA. Clinical review 27: Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women. J Clin Endocrinol Metab 1991;73:925-930.
9. [9] Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991;325:1196-1204.
10. [10] Colburn P, Buonassisi V. Estrogen-binding sites in endothelial cell cultures. Science 1978;201:817-819.
11. [11] Nakao J, Chang W-C, Murota S-I, Orimo H. Estradiol-binding sites in rat aortic smooth muscle cells in culture. Atherosclerosis 1981;38:75-80.
12. [12] Orimo A, Inoue S, Ikegami A, Hosoi T, Akishita M, Ouchi Y, Muramatsu M, Orimo H. Vascular smooth muscle cells as target for estrogen. Biochem Biophys Res Commun 1993;195:730-736.
13. [13] Karas RH, Patterson BL, Mendelsohn ME. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 1994;89:1943-1950.
14. [14] Jiang C, Sarrel PM, Lindsay DC, Poole-Wilson PA, Collins P. Endothelium-independent relaxation of rabbit coronary artery by 17β-oestradiol in vitro. Br J Pharmacol 1991;104:1033-1037.
15. 2+ release induced by thromboxane A2 in porcine coronary artery. Circulation 1995;91:2619-2626.
16. [16] Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 1990;81:1680-1687.
17. [17] Reis SE, Gloth ST, Blumenthal RS, Resar JR, Zacur HA, Gerstenblith G, Brinker JA. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 1994;89:52-60.
18. [18] Van Buren G, Yang D, Clark KE. Estrogen-induced uterine vasodilation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am J Obstet Gynecol 1992;16:828-833.
19. [19] Rosselli M, Imthurn B, Keller PJ, Jackson EK, Dubey RK. Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17β-estradiol and norethisterone acetate. A two-year follow-up study. Hypertension 1995;25(part 2):848-853.
20. [20] Seillan C, Ody C, Russo-Marie F, Duval D. Differential effects of sex steroids on prostaglandin synthesis by male and female cultured piglet endothelial cells. Prostaglandins 1983;26:3-12.
21. [21] Chang W-C, Nakao J, Orimo H, Murota S-I. Stimulation of prostacyclin biosynthetic activity by estradiol in rat aortic smooth muscle cells in culture. Biochem Biophys Acta 1980;619:107-118.
22. [22] Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-415.
23. [23] Komuro I, Kurihara H, Sugiyama T, Takaku F, Yazaki Y. Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett 1988;238:249-252.
24. [24] Hirata Y, Takagi Y, Fukuda Y, Marumo F. Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 1989;78:225-228.
25. [25] Alberts GF, Peifley KA, Johns A, Kleha JF, Winkles JA. Constitutive endothelin-1 overexpression promotes smooth muscle cell proliferation via an external autocrine loop. J Biol Chem 1994;269:10112-10118.
26. [26] Miyauchi T, Yanagisawa M, Tomizawa T, Sugishita Y, Suzuki N, Fujino M, Ajisaka R, Goto K, Masaki T. Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction. Lancet 1989;2:53-54.
27. [27] Lerman A, Brooks SE, Hallett JW, Heublein DM, Sandberg SM, Burnett JC. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 1991;325:997-1001.
28. [28] Douglas SA, Louden C, Vickery-Clark LM, Storer BL, Hart T, Feuerstein GZ, Elliott JD, Ohlstein EH. A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty: protective effects of the novel nonpeptide endothelin receptor antagonist SB 209670. Circ Res 1994;75:190-197.
29. [29] Kaczmarek L, Kaminska B. Molecular biology of cell activation. Exp Cell Res 1989;183:24-35.
30. [30] Curran T, Bravo R, Muller R. Transient induction of c-fos and c-myc in an immediate consequence of growth factor stimulation. Cancer Surv 1985;4:655-681.
31. [31] Suzuki N, Matsumoto H, Kitada C, Masaki T, Fujino M. A sensitive sandwich-enzyme immunoassay for human endothelin. J Immunol Method 1989;118:245-250.
32. [32] Ouchi Y, Share L, Crofton JT, Iitake K, Brooks D. Sex differences in the development of deoxycorticosterone-salt hypertension in the rat. Hypertension 1987;9:172-177.
33. [33] Gibbs FP, Vriend J. The half-life of melatonin elimination from rat plasma. Endocrinology 1981;109:1796-1798.
34. [34] Urban RJ, Padmanabhan V, Beitins I, Veldhuis JD. Metabolic clearance of human follicle-stimulating hormone assessed by radioimmunoassay, immunoradiometric assay, and in vitro Sertoli cell bioassay. J Clin Endocrinol Metab 1991;73:818-823.
35. 2+ level and contraction in the rat aorta. Endothelium-dependent and -independent mechanisms. Circ Res 1995;77:673-678.
36. [36] Matsumoto H, Suzuki N, Onda H, Fujino M. Abundance of endothelin-3 in rat intestine, pituitary gland and brain. Biochem Biophys Res Commun 1989;164:74-80.
37. [37] Inoue S, Orimo A, Hosoi T, Matsuse T, Hashimoto M, Yamada R, Ouchi Y, Orimo H, Muramatsu M. Expression of follistatin, an activin-binding protein, in vascular smooth muscle cells and arteriosclerotic lesions. Arterioscler Thromb 1993;13:1859-1864.
38. [38] Hamaoki M, Kato H, Sugi M, Fujimoto M, Kurihara H, Yoshizumi M, Yanagisawa M, Kimura S, Masaki T, Yazaki Y. Monoclonal antibodies to endothelin: application for sandwich immunoassays. Hybridoma 1990;9:63-69.
39. [39] Chirgwin JM, Przybyla AE, Macdonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acids from sources enriched in ribonuclease. Biochemistry 1979;18:5294-5299.
40. [40] Miyauchi T, Yanagisawa M, Iida K, Ajisaka R, Suzuki N, Fujino M, Goto K, Masaki T, Sugishita Y. Age-and sex-related variation of plasma endothelin-1 concentration in normal and hypertensive subjects. Am Heart J 1992;123:1092-1093.
41. [41] Polderman KH, Stehouwer CDA, van Kamp GJ, Dekker GA, Verheugt FWA, Gooren LJG. Influence of sex hormones on plasma endothelin levels. Ann Intern Med 1993;118:429-432.
42. [42] Imai T, Hirata Y, Emori T, Yanagisawa M, Masaki T, Marumo F. Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells. Hypertension 1992;19:753-757.
43. [43] Winkles JA, Alberts GF, Brogi E, Libby P. Endothelin-1 and endothelin receptor mRNA expression in normal and atherosclerotic human arteries. Biochem Biophys Res Commun 1993;191:1081-1088.
44. [44] Vargas R, Wroblewska B, Rego A, Hatch J, Ramwell PW. Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery. Br J Pharmacol 1993;109:612-617.
45. [45] Green S, Chambon P. Nuclear receptors enhance our understanding of transcription regulation. Trends Genet 1988;4:309-314.
46. [46] Evans RM. The steroid and thyroid hormone receptor superfamily. Science 1988;240:889-895.
47. [47] Beato M. Gene regulation by steroid hormones. Cell 1989;56:335-344.
48. [48] Inoue A, Yanagisawa M, Takuwa Y, Mitsui Y, Kobayashi M, Masaki T. The human preproendothelin-1 gene: complete nucleotide sequence and regulation of expression. J Biol Chem 1989;264:14954-14959.
49. [49] Weisz A, Bresciani F. Estrogen induces expression of c-fos and c-myc protooncogenes in rat uterus. Mol Endocrinol 1988;2:816-824.
50. [50] Weisz A, Rosales R. Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor. Nucl Acids Res 1990;18:5097-5106.
51. [51] Dilley RJ, McGeachie JK, Prendergast FJ. A review of the proliferative behaviour, morphology and phenotypes of vascular smooth muscle. Atherosclerosis 1987;63:99-107.